Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03903120
PHASE1

ASSIST: Treatment for Childhood Apraxia of Speech

Sponsor: Temple University

View on ClinicalTrials.gov

Summary

Childhood apraxia of speech (CAS) is a pediatric motor speech disorder that impairs the planning of movements needed for intelligible speech. Children with CAS often show little or slow progress in standard speech therapy. This research is a Phase 1 study that tests initial efficacy and optimal parameters of a theoretically based integral stimulation treatment called ASSIST (Apraxia of Speech Systematic Integral Stimulation Treatment). In three small randomized group design studies, children (N=20 per study) receive 16 hours of individual ASSIST. The three studies systematically investigate treatment intensity (2 vs. 4 weeks) and two critical aspects of target selection: complexity (simple vs. complex target) and lexicality (words vs. nonwords). Each study also systematically examines the effect of treatment on functional outcome measures, including parent ratings of intelligibility and communicative participation, and objective intelligibility measures obtained from unfamiliar listeners.

Official title: ASSIST: Child Apraxia Speech Treatment

Key Details

Gender

All

Age Range

4 Years - 9 Years

Study Type

INTERVENTIONAL

Enrollment

420

Start Date

2019-04-18

Completion Date

2025-03-31

Last Updated

2025-03-04

Healthy Volunteers

Yes

Interventions

BEHAVIORAL

ASSIST

Integral stimulation based treatment ("watch me, listen to me, say what I say") for CAS that is based on principles of motor learning and neuroplasticity and includes a systematic approach to adaptive practice. Treatment includes a focus on prosody, use of visual, tactile, auditory cues, slowing speech rate, and large amounts of practice.

Locations (1)

Temple University

Philadelphia, Pennsylvania, United States